Article
Integrating interacting drugs and genetic variations to improve the predictability of warfarin maintenance dose in Chinese patients.
Pharmacogenetics and genomics - 1 Mar 2012
Zhong Shi-Long, Yu Xi-Yong, Liu Yuan, Xu Dan, Mai Li-Ping, Tan Hong-Hong, Lin Qiu-Xiong, Yang Min, Lin Shu-Guang
Abstract excerpt
OBJECTIVE: Compared with genetic factors, drug interactions are largely unexplored in pharmacogenetic studies. This study sought to systematically investigate the effects of VKORC1, STX4A, CYP2C9, CYP4F2, CYP3A4, and GGCX gene polymorphisms and interacting drugs on warfarin maintenance dose. METHODS: A retrospective study of 845 Chinese patients after heart valve replacement receiving long-term warfarin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
